Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy O Martínez-Sáez, PG Borau, T Alonso-Gordoa, J Molina-Cerrillo, ... Critical reviews in oncology/hematology 111, 117-123, 2017 | 120 | 2017 |
Bruton’s tyrosine kinase (BTK) as a promising target in solid tumors J Molina-Cerrillo, T Alonso-Gordoa, P Gajate, E Grande Cancer Treatment Reviews 58, 41-50, 2017 | 118 | 2017 |
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis M Santoni, A Rizzo, J Kucharz, V Mollica, M Rosellini, A Marchetti, ... Cancer Immunology, Immunotherapy 72 (6), 1365-1379, 2023 | 116 | 2023 |
BRAF mutated colorectal cancer: New treatment approaches J Molina-Cerrillo, M San Román, J Pozas, T Alonso-Gordoa, M Pozas, ... Cancers 12 (6), 1571, 2020 | 66 | 2020 |
Tyrosine kinase receptors in oncology J Esteban-Villarrubia, JJ Soto-Castillo, J Pozas, M San Román-Gil, ... International journal of molecular sciences 21 (22), 8529, 2020 | 61 | 2020 |
Targeting tyrosine kinases in renal cell carcinoma:“new bullets against old guys” T Alonso-Gordoa, ML García-Bermejo, E Grande, P Garrido, A Carrato, ... International journal of molecular sciences 20 (8), 1901, 2019 | 49 | 2019 |
New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects? A Barquín-García, J Molina-Cerrillo, P Garrido, D Garcia-Palos, A Carrato, ... European Journal of Internal Medicine 66, 1-8, 2019 | 35 | 2019 |
Molecular mechanisms of resistance to immunotherapy and antiangiogenic treatments in clear cell renal cell carcinoma PÁ Ballesteros, J Chamorro, MS Román-Gil, J Pozas, ... Cancers 13 (23), 5981, 2021 | 32 | 2021 |
The PALBONET Trial: A phase II study of palbociclib in metastatic grade 1 and 2 pancreatic neuroendocrine tumors (GETNE‐1407) E Grande, A Teulé, T Alonso‐Gordoa, P Jiménez‐Fonseca, M Benavent, ... The Oncologist 25 (9), 745-e1265, 2020 | 29 | 2020 |
Inhibition of peripheral synthesis of serotonin as a new target in neuroendocrine tumors J Molina-Cerrillo, T Alonso-Gordoa, O Martínez-Sáez, E Grande The Oncologist 21 (6), 701-707, 2016 | 29 | 2016 |
Novel molecular characterization of colorectal primary tumors based on miRNAs E Conde, A Pascual, D Prieto-Cuadra, VF Laza, J Molina-Cerrillo, ... Cancers 11 (3), 346, 2019 | 28 | 2019 |
Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach M Araujo-Castro, E Pascual-Corrales, L Nattero Chavez, A Martínez Lorca, ... Journal of Endocrinological Investigation 44, 2545-2555, 2021 | 22 | 2021 |
Targeting angiogenesis in pancreatic neuroendocrine tumors: resistance mechanisms J Pozas, M San Román, T Alonso-Gordoa, M Pozas, L Caracuel, ... International journal of molecular sciences 20 (19), 4949, 2019 | 22 | 2019 |
Cabozantinib in patients with advanced renal cell carcinoma primary refractory to first-line immunocombinations or tyrosine kinase inhibitors M Santoni, F Massari, S Bracarda, E Grande, MR Matrana, M Rizzo, ... European Urology Focus 8 (6), 1696-1702, 2022 | 19 | 2022 |
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial E Grande, C Rodriguez-Antona, C López, T Alonso-Gordoa, M Benavent, ... The Oncologist 26 (11), 941-949, 2021 | 17 | 2021 |
Immunotherapy in adrenocortical carcinoma: predictors of response, efficacy, safety, and mechanisms of resistance M Araujo-Castro, E Pascual-Corrales, J Molina-Cerrillo, T Alonso-Gordoa Biomedicines 9 (3), 304, 2021 | 17 | 2021 |
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies M San Roman-Gil, J Pozas, D Rosero-Rodriguez, J Chamorro-Perez, ... Cancer treatment reviews 105, 102372, 2022 | 15 | 2022 |
Prognostic and predictive role of the PI3K–AKT–mTOR pathway in neuroendocrine neoplasms P Gajate, T Alonso-Gordoa, O Martínez-Sáez, J Molina-Cerrillo, E Grande Clinical and Translational Oncology 20, 561-569, 2018 | 14 | 2018 |
Primary sarcomatoid tumor of the bladder: a different entity but the same approach? J Molina-Cerrillo, O Martínez-Sáez, T Alonso-Gordoa, P Tirado-Zambrano, ... Clinical Genitourinary Cancer 13 (6), 493-498, 2015 | 12 | 2015 |
Bronchial carcinoids: from molecular background to treatment approach M Araujo-Castro, E Pascual-Corrales, J Molina-Cerrillo, N Moreno Mata, ... Cancers 14 (3), 520, 2022 | 11 | 2022 |